This report provides a comprehensive financial analysis of Acrux Limited, a pharmaceutical company. It includes the company's ownership and governance structure, fundamental ratios, liquidity ratios, long-term solvency, asset management, profitability ratios, market value ratios, and monthly share price and index movement. The report also covers internet research on financial measures, beta, required rate of return as per CAPM, conservative investment, weighted average cost of capital (WACC), debt ratio, dividend policy, and a letter of recommendation.